Q2 2025

Filed Aug 8, 2025 · 10-Q · 39 days after period end · 0001641172-25-022766

Q2 2025 · 10-Q

Revenue—

Net Income

-$2.27M

N/M vs Q2 2024

EPS Diluted

-$3.10

N/M vs Q2 2024

Operating Income-$1,714,202N/M

Operating Cash Flowderived-$1,314,370N/M

Same quarter

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Revenue	—	—	$13.16K	$30.39K
Net Income	-$2.27M	-$2.31M	-$3.05M	-$3.59M
EPS Diluted	-$3.10	-$15.27	-$1.51	-$1.85

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR